Surmodics Announces FTC Does Not Intend to Appeal Denial of Injunction, Order Preventing Closing Set to Expire TodayBusiness Wire • 11/17/25
Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCRBusiness Wire • 11/11/25
Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia PresentationsBusiness Wire • 11/04/25
Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3Business Wire • 11/03/25
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 08/08/25
Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial GuidanceBusiness Wire • 08/08/25
Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8Business Wire • 08/06/25
SRDX Stock Down Following Q2 Earnings Miss, Gross Margin ContractsZacks Investment Research • 05/01/25
SurModics (SRDX) Reports Q2 Earnings: What Key Metrics Have to SayZacks Investment Research • 04/30/25
Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial GuidanceBusiness Wire • 04/30/25
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30Business Wire • 04/28/25
Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated BalloonBusiness Wire • 04/22/25
SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy SystemZacks Investment Research • 04/04/25
Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral ArteriesBusiness Wire • 04/03/25
Here's Why You Should Retain Surmodics Stock in Your Portfolio NowZacks Investment Research • 03/18/25
SRDX Stock Falls Following Plan for Legal Action Against FTC ChallengeZacks Investment Research • 03/07/25
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCRBusiness Wire • 03/07/25
FTC sues to block private equity firm's deal to buy medical device coatings maker SurmodicsReuters • 03/06/25